![[OncoHost in Targeted Oncology] PROPHETIC Study of Immunotherapy Diagnostic Adds New Site in Buffalo, NY](https://blog.ourcrowd.com/wp-content/uploads/2022/04/targeted-oncology.png)
Roswell Park Comprehensive Cancer Center will be joining the investigation of OncoHost’s PROphet precision oncology analysis platform and launching a clinical site in Buffalo, New York, according to a press release from OncoHost.1 Read more...
Read More![[OncoHost in The Times of Israel] 2nd Israeli to blast off to space, will perform experiments seeking health advances](https://blog.ourcrowd.com/wp-content/uploads/2017/10/the-times-of-israel-NEW.jpg)
Eytan Stibbe boldly goes where no Israeli has gone before — the ISS — amid hopes of gaining insights into range of conditions, including immune problems and Alzheimer’s Read...
Read More![[OncoHost in PR Newswire] OncoHost Announces Clinical Trial Collaboration with Roswell Park Comprehensive Cancer Center to Analyze Immunotherapy Resistance](https://blog.ourcrowd.com/wp-content/uploads/2017/09/PR_newswire.jpg)
BINYAMINA, Israel, April 5, 2022 /PRNewswire/ — OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced today that Roswell Park Comprehensive Cancer Center has joined its PROPHETIC study, launching a clinical site in Buffalo, New York. Read...
Read More![[OncoHost in Technology Networks] Driving progress in personalized cancer therapy](https://blog.ourcrowd.com/wp-content/uploads/2022/05/technology_networks.png)
Treatment resistance to cancer therapy can be a major stumbling block in a patient’s clinical journey, but it can be addressed with combination therapy or personalized medicine. Read more...
Read More
Israeli startup OncoHost predicts which specialized therapies will be most effective for late-stage cancer. Read...
Read More
